changing the Company’s seal, and still using the ticker of “EASON” 6.2 The change of Company’s Memorandum of association 1) Amend clause 1 (Company’s name) to be consistent with the change of the Company’s
*( & '%*-#H $ TCR /* /%$$$ * %B`+'* && #% A(* * ". * VEMEX Description Ticker Market ISIN CODE CUSIP CODE Ishares MSCI Pacific ex Japan Index Fund EPP AMEX US4642866655 464286665 Telefonaktiebolaget
Ticker ARKG CUSIP 00214Q 302 ISIN US00214Q3020 ดชันีชีว้ดั/อ้างอิง(Benchmark) - NASDAQ Biotech. Index - S&P 500 Index - MSCI World Index Index ticker - XNBI Index - SPX Index - M1WO Index สกลุเงิน USD ผู้
Depositary Receipt) ตลาดหลกัทรัพย์ท่ีจดทะเบยีน ตลาดหลกัทรัพย์นิวยอร์ก (NYSE Arca) ประเทศสหรัฐอเมริกา วนัจดัตัง้กองทนุ 30 กนัยายน 2557 การเปิดให้ซือ้และขายคืนหน่วยลงทนุ ทกุวนัท าการซือ้ขายหน่วยลงทนุ Fund Ticker
agreements and booking 3 Calculated from interest-bearing debt net of cash and cash equivalents 4 Including rental and service income, marketing commission income, project management fee, interest, and others
the resolution of the Council of Ministers and shall be authorized to approve details of the agreements, as well as taking any necessary actions in order to sign the agreements with EXAT until
increase of THB 46.6mn. All comparisons of changes in this report are based on the adjusted accounting policy and reclassification. 1 Backlogs include only sold units with sale and purchase agreements 2
% Current portion of liabilities under financial lease agreements 33 33 -2% Other non-current liabilities 346 349 -1% Total Current Liabilities 2,417 2,517 -4% Long-term loans, net of current portion from
liabilities under financial lease agreements 33 33 -2% Other non-current liabilities 340 349 -3% Total Current Liabilities 2,408 2,517 -4% Long-term loans, net of current portion from financial institutions 655
purchase agreement and/or relevant agreements and complete the transfer of BS Myco Biotech shares on June 12, 2019. This Acquisition is considered as the assets acquisition transaction of listed company and